среда, 19 сентября 2012 г.

BayCare Behavioral Health and Homeless Emergency Project Receive Federal Grant to Help Break the Cycle of Homelessness. - Biotech Week

BayCare Behavioral Health and the Homeless Emergency Project have received a five-year grant of $400,000 for each year for a total of $2 million from the U.S. Department of Health and Human Services Substance Abuse and Mental Health Services Administration (SAMHSA) Center for Substance Abuse Treatment (CSAT) (see also Mental Health).

'This grant gives us the opportunity to combine housing assistance with treatment services for mental health and substance abuse issues,' said Bruce Fyfe, chairman of the board, Homeless Emergency Project. By helping our clients address their mental health and substance abuse issues, we hope to help them effectively end the cycle of chronic homelessness.'

With the grant, BayCare Behavioral Health will partner with Homeless Emergency Project to provide assistance for homeless individuals and families who reside in Homeless Emergency Project housing facilities, also known as supportive housing. Together, the two organizations will develop outreach, direct treatment programs and other support services for homeless individuals and families with serious psychiatric conditions or substance abuse issues.

'We know that many people who are homeless have unmet mental health and substance abuse treatment needs,' stated John Sheehan, vice president, behavioral health services, BayCare Health System. 'Being homeless makes it close to impossible for someone to receive the type of consistent treatment and support needed to achieve recovery.'

According to statistics from the Pinellas County Coalition for the Homeless, 42 percent of homeless adults have a long-term disabling condition and of those, 45 percent experience mental health issues and 29 percent deal with substance abuse.

Keywords: Behavior, Mental Health, BayCare Health System.

This article was prepared by Biotech Week editors from staff and other reports. Copyright 2009, Biotech Week via NewsRx.com.